Front Cover
Laboratory Study, published in Stem Cells Transl Med (2018) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Stem Cells Transl Med (2018)
- Reported sample size
- —
- Source database
- Europe PMC
- PMCID
- PMC5827739
Abstract (original English)
Cover Art: [Lower left]: Histology slide of H&E (hematoxylin & eosin) staining of a rat anal sphincter injury treated with injections of human adipose stem cells (hASCs) combined with polyacrylamide hydrogel (Bulkamid) at 4 weeks after the injections. [Upper right]: Smooth muscle actin staining for detection of muscle tissue in rat anal sphincter, a sample of a control of polyacrylamide hydrogel only, at 4 weeks. See Kuismanen et al. beginning on page 295.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.